<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Dermatologic Oncology News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/404</link> 
<description>Dermatologic Oncology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2935341</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Cancer</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2935341</guid>
</item> 
 

<item> 
<title><![CDATA[Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940854</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Journal of Clinical Oncology</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940854</guid>
</item> 


 

<item> 
<title><![CDATA[Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939498</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Clinical Cancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2939498</guid>
</item> 
 
 


  


</channel> 
</rss>

